 |
|
Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection
Benigno Rodríguez, MD, MSc;
Ajay K. Sethi, PhD, MHS;
Vinay K. Cheruvu, MSc, MS;
Wilma Mackay, MS;
Ronald J. Bosch, PhD;
Mari Kitahata, MD, MPH;
Stephen L. Boswell, MD;
W. Christopher Mathews, MD, MSPH;
David R. Bangsberg, MD;
Jeffrey Martin, MD;
Christopher C. Whalen, MD, MS;
Scott Sieg, PhD;
Suhrida Yadavalli, MSM-IS;
Steven G. Deeks, MD;
Michael M. Lederman, MD
JAMA. 2006;296:1498-1506.
Context Plasma human immunodeficiency virus (HIV) RNA level predicts HIV disease progression, but the extent to which it explains the variability in rate of CD4 cell depletion is poorly characterized.
Objective To estimate the proportion of variability in rate of CD4 cell loss predicted by presenting plasma HIV RNA levels in untreated HIV-infected persons.
Design Repeated-measures analyses of 2 multicenter cohorts, comprising observations beginning on May 12, 1984, and ending on August 26, 2004. Analyses were conducted between August 2004 and March 2006.
Setting Two cohorts of HIV-infected persons: patients followed up at 4 US teaching medical institutions or participating in either the Research in Access to Care for the Homeless Cohort (REACH) or the San Francisco Men's Health Study (SFMHS) cohorts and participants in the Multicenter AIDS Cohort Study (MACS) cohort.
Participants Antiretroviral treatment–naive, chronically HIV-infected persons (n = 1289 and n = 1512 for each of the 2 cohorts) untreated during the observation period ( 6 months) and with at least 1 HIV RNA level and 2 CD4 cell counts available. Approximately 35% were nonwhite, and 35% had risk factors other than male-to-male sexual contact.
Main Outcome Measures The extent to which presenting plasma HIV RNA level could explain the rate of model-derived yearly CD4 cell loss, as estimated by the coefficient of determination (R2).
Results In both cohorts, higher presenting HIV RNA levels were associated with greater subsequent CD4 cell decline. In the study cohort, median model–estimated CD4 cell decrease among participants with HIV RNA levels of 500 or less, 501 to 2000, 2001 to 10 000, 10 001 to 40 000, and more than 40 000 copies/mL were 20, 39, 48, 56, and 78 cells/µL, respectively. Despite this trend across broad categories of HIV RNA levels, only a small proportion of CD4 cell loss variability (4%-6%) could be explained by presenting plasma HIV RNA level. Analyses using multiple HIV RNA measurements or restricting to participants with high HIV RNA levels improved this correlation minimally (R2, 0.09), and measurement error was estimated to attenuate these associations only marginally (deattenuated R2 in the 2 cohorts, 0.05 and 0.08, respectively).
Conclusions Presenting HIV RNA level predicts the rate of CD4 cell decline only minimally in untreated persons. Other factors, as yet undefined, likely drive CD4 cell losses in HIV infection. These findings have implications for treatment decisions in HIV infection and for understanding the pathogenesis of progressive immune deficiency.
Author Affiliations: Center for AIDS Research (Drs Rodríguez, Sieg, and Lederman, and Mrs Yadavalli), Center for Modern Epidemiology of Infectious Diseases (Drs Sethi and Whalen and Mr Cheruvu and Ms Mackay), Case Western Reserve University, Cleveland, Ohio; Department of Biostatistics, Harvard School of Public Health, Harvard University, Boston, Mass (Dr Bosch); Department of Medicine, University of Washington, Seattle (Dr Kitahata); Department of Medicine, Harvard University School of Medicine, Boston, Mass (Dr Boswell); Department of Medicine, University of California, San Diego (Dr Mathews); Department of Medicine and Epidemiology (Drs Bangsberg and Martin) and Department of Medicine (Dr Deeks), University of California, San Francisco.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline
Geoffrey S. Gottlieb, Stephen E. Hawes, David C. Nickle, Joshua T. Herbeck, Nancy B. Kiviat, James I. Mullins, and Papa Salif Sow
JAMA. 2007;297(8):805.
EXTRACT
| FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline
Viviane D. Lima, Robert S. Hogg, and Julio S. G. Montaner
JAMA. 2007;297(8):805-806.
EXTRACT
| FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline—Reply
Benigno Rodriguez, Michael M. Lederman, Ajay K. Sethi, Vinay K. Cheruvu, Ronald J. Bosch, Jeffrey Martin, and Steven Deeks
JAMA. 2007;297(8):806-807.
EXTRACT
| FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline—Reply
W. Keith Henry and Pablo Tebas
JAMA. 2007;297(8):807.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Explaining, Predicting, and Treating HIV-Associated CD4 Cell Loss: After 25 Years Still a Puzzle
W. Keith Henry, Pablo Tebas, and H. Clifford Lane
JAMA. 2006;296(12):1523-1525.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Vaccine-Induced, Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduce Virus Replication but Do Not Protect from Simian Immunodeficiency Virus Disease Progression
Engram et al.
J. Immunol. 2009;183:706-717.
ABSTRACT
| FULL TEXT
Association Between HIV-1 RNA Level and CD4 Cell Count Among Untreated HIV-Infected Individuals
Lima et al.
AJPH 2009;99:S193-S196.
ABSTRACT
| FULL TEXT
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells
Catalfamo et al.
Proc. Natl. Acad. Sci. USA 2008;105:19851-19856.
ABSTRACT
| FULL TEXT
Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy
Byrnes et al.
J. Leukoc. Biol. 2008;84:1447-1453.
ABSTRACT
| FULL TEXT
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Kitahata et al.
Int J Epidemiol 2008;37:948-955.
FULL TEXT
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
Brenchley et al.
Blood 2008;112:2826-2835.
ABSTRACT
| FULL TEXT
Cost-effectiveness of HIV Monitoring Strategies in Resource-Limited Settings: A Southern African Analysis
Bendavid et al.
Arch Intern Med 2008;168:1910-1918.
ABSTRACT
| FULL TEXT
S-phase entry leads to cell death in circulating T cells from HIV-infected persons
Sieg et al.
J. Leukoc. Biol. 2008;83:1382-1387.
ABSTRACT
| FULL TEXT
Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection
Long et al.
J. Virol. 2008;82:4785-4792.
ABSTRACT
| FULL TEXT
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection
Ndhlovu et al.
J. Leukoc. Biol. 2008;83:254-262.
ABSTRACT
| FULL TEXT
Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay
Oliver et al.
J. Clin. Microbiol. 2007;45:3616-3619.
ABSTRACT
| FULL TEXT
Progressive CD4+ central-memory T cell decline results in CD4+ effector-memory insufficiency and overt disease in chronic SIV infection
Okoye et al.
JEM 2007;204:2171-2185.
ABSTRACT
| FULL TEXT
Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence
Pandrea et al.
J. Immunol. 2007;179:3035-3046.
ABSTRACT
| FULL TEXT
Prognostic Value of HIV-1 RNA, CD4 Cell Count, and CD4 Cell Count Slope for Progression to AIDS and Death in Untreated HIV-1 Infection
Mellors et al.
JAMA 2007;297:2349-2350.
FULL TEXT
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1
Biancotto et al.
Blood 2007;109:4272-4279.
ABSTRACT
| FULL TEXT
Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Gange et al.
Int J Epidemiol 2007;36:294-301.
FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline
Gottlieb et al.
JAMA 2007;297:805-805.
FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline--Reply
Henry and Tebas
JAMA 2007;297:807-807.
FULL TEXT
Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline
Lima et al.
JAMA 2007;297:805-806.
FULL TEXT
Cocaine Dependence and Acute Cocaine Induce Decreases of Monocyte Proinflammatory Cytokine Expression across the Diurnal Period: Autonomic Mechanisms
Irwin et al.
J. Pharmacol. Exp. Ther. 2007;320:507-515.
ABSTRACT
| FULL TEXT
CD4-Cell Decline Not Predicted by Viral Load
AIDS Clin Care 2006;2006:1-1.
FULL TEXT
What's new in the other general journals
Tonks
BMJ 2006;333:744-745.
FULL TEXT
Predicting CD4-Cell Decline in HIV-Infected Patients
JWatch Infect. Diseases 2006;2006:3-3.
FULL TEXT
Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle.
Henry et al.
JAMA 2006;296:1523-1525.
FULL TEXT
|
